APP and Alzheimer disease: Interestingly, in a recent in vivo experiment using transgenic APP/PS1 AD mouse model, OA attenuated cognitive deficits by stimulating the Wingless/integrated (Wnt)/GSK-3β/β-catenin pathway [242].